自噬
FOXO3公司
细胞生物学
骨骼肌
生物
转录因子
肌肉萎缩
蛋白激酶B
体内
蛋白酶体
溶酶体
TFEB
心肌细胞
癌症研究
信号转导
生物化学
基因
解剖
细胞凋亡
酶
遗传学
作者
Cristina Mammucari,Giulia Milan,Vanina Romanello,Eva Masiero,Rüdiger Rudolf,Paola Del Piccolo,Steven J. Burden,Raffaella Di Lisi,Claudia Sandri,Jinghui Zhao,Alfred Lewis Goldberg,Stefano Schiaffino,Marco Sandri
出处
期刊:Cell Metabolism
[Cell Press]
日期:2007-12-01
卷期号:6 (6): 458-471
被引量:2182
标识
DOI:10.1016/j.cmet.2007.11.001
摘要
Autophagy allows cell survival during starvation through the bulk degradation of proteins and organelles by lysosomal enzymes. However, the mechanisms responsible for the induction and regulation of the autophagy program are poorly understood. Here we show that the FoxO3 transcription factor, which plays a critical role in muscle atrophy, is necessary and sufficient for the induction of autophagy in skeletal muscle in vivo. Akt/PKB activation blocks FoxO3 activation and autophagy, and this effect is not prevented by rapamycin. FoxO3 controls the transcription of autophagy-related genes, including LC3 and Bnip3, and Bnip3 appears to mediate the effect of FoxO3 on autophagy. This effect is not prevented by proteasome inhibitors. Thus, FoxO3 controls the two major systems of protein breakdown in skeletal muscle, the ubiquitin-proteasomal and autophagic/lysosomal pathways, independently. These findings point to FoxO3 and Bnip3 as potential therapeutic targets in muscle wasting disorders and other degenerative and neoplastic diseases in which autophagy is involved.
科研通智能强力驱动
Strongly Powered by AbleSci AI